Alzheimer’s disease therapies in phase III development 2023, by type

Published by
Matej Mikulic,
Jun 6, 2023
As of January 1, 2023, 31 percent of Alzheimer’s disease drugs in clinical trial phase III of development worldwide addressed transmitter receptor mechanisms. This statistic illustrates Alzheimer’s disease drugs in phase III of development worldwide as of early 2023, by type.

Alzheimer’s disease drugs in clinical trial phase III worldwide as of 2023, by type

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

March 2023

Region

Worldwide

Survey time period

as of January 1, 2023

Supplementary notes

There were 36 Alzheimer's disease drugs in phase III as of January 1, 2023.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$229 USD $199 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

5

Other regions

10

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in ChinaCoronavirus COVID-19 in ChinaPharmaceutical industry in JapanVaccine industry in ChinaPharmaceuticals in India
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu